De-Differentiation Confers Multidrug Resistance Via Noncanonical PERK-Nrf2 Signaling

Malignant carcinomas that recur following therapy are typically de-differentiated and multidrug resistant (MDR). De-differentiated cancer cells acquire MDR by up-regulating reactive oxygen species (ROS)–scavenging enzymes and drug efflux pumps, but how these genes are up-regulated in response to de-...

Descripción completa

Detalles Bibliográficos
Autores principales: Del Vecchio, Catherine A., Feng, Yuxiong, Sokol, Ethan S., Tillman, Erik J., Sanduja, Sandhya, Reinhardt, Ferenc, Gupta, Piyush B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159113/
https://www.ncbi.nlm.nih.gov/pubmed/25203443
http://dx.doi.org/10.1371/journal.pbio.1001945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159113/
https://www.ncbi.nlm.nih.gov/pubmed/25203443
http://dx.doi.org/10.1371/journal.pbio.1001945

Ejemplares similares